Global Ocular Drug Delivery Market Research Report 2017

November 2017 | 105 pages | ID: G4B2B3073DEEN
QYResearch

Abstracts

In this report, the global Ocular Drug Delivery market is valued at USD XX million in 2016 and is expected to reach USD XX million by the end of 2022, growing at a CAGR of XX% between 2016 and 2022.

Geographically, this report is segmented into several key Regions, with production, consumption, revenue (million USD), market share and growth rate of Ocular Drug Delivery in these regions, from 2012 to 2022 (forecast), covering

• North America
• Europe
• China
• Japan
• Southeast Asia
• India

Global Ocular Drug Delivery market competition by top manufacturers, with production, price, revenue (value) and market share for each manufacturer; the top players including

• OCULAR THERAPEUTIX, INC
• Alimera Sciences
• Allergan, Plc
• EyeGate Pharma
• Valeant Pharmaceuticals International, Inc
• Envisia Therapeutics
• Clearside Biomedical
• Graybug Vision Inc
• Taiwan Liposome Company
• Santen Pharmaceutical Co., Ltd

On the basis of product, this report displays the production, revenue, price, market share and growth rate of each type, primarily split into

• By Technology
• Ocular Insert
• Iontophoresis
• Intraocular Implants
• In Situ Gel & Punctal Plugs
• Others
• By Form
• Solution
• Suspension
• Emulsion
• Liposomes & Nanoparticles
• Ointment

On the basis of the end users/applications, this report focuses on the status and outlook for major applications/end users, consumption (sales), market share and growth rate for each application, including

• Hospitals
• Ambulatory Surgical Centers
• Ophthalmic Clinics
• Homecare Settings

If you have any special requirements, please let us know and we will offer you the report as you want.

Contents

Global Ocular Drug Delivery Market Research Report 2017

1 OCULAR DRUG DELIVERY MARKET OVERVIEW

1.1 Product Overview and Scope of Ocular Drug Delivery
1.2 Ocular Drug Delivery Segment By Technology
  1.2.1 Global Ocular Drug Delivery Production and CAGR (%) Comparison By Technology (Product Category)(2012-2022)
  1.2.2 Global Ocular Drug Delivery Production Market Share By Technology (Product Category) in 2016
  1.2.3 Ocular Insert
  1.2.4 Iontophoresis
  1.2.5 Intraocular Implants
  1.2.6 In Situ Gel & Punctal Plugs
  1.2.7 Others
1.3 Ocular Drug Delivery Segment By Form
  1.3.1 Solution
  1.3.2 Suspension
  1.3.3 Emulsion
  1.3.4 Liposomes & Nanoparticles
  1.3.5 Ointment
1.4 Global Ocular Drug Delivery Segment by Application
  1.4.1 Ocular Drug Delivery Consumption (Sales) Comparison by Application (2012-2022)
  1.4.2 Hospitals
  1.4.3 Ambulatory Surgical Centers
  1.4.4 Ophthalmic Clinics
  1.4.5 Homecare Settings
1.5 Global Ocular Drug Delivery Market by Region (2012-2022)
  1.5.1 Global Ocular Drug Delivery Market Size (Value) and CAGR (%) Comparison by Region (2012-2022)
  1.5.2 North America Status and Prospect (2012-2022)
  1.5.3 Europe Status and Prospect (2012-2022)
  1.5.4 China Status and Prospect (2012-2022)
  1.5.5 Japan Status and Prospect (2012-2022)
  1.5.6 Southeast Asia Status and Prospect (2012-2022)
  1.5.7 India Status and Prospect (2012-2022)
1.6 Global Market Size (Value) of Ocular Drug Delivery (2012-2022)
  1.6.1 Global Ocular Drug Delivery Revenue Status and Outlook (2012-2022)
  1.6.2 Global Ocular Drug Delivery Capacity, Production Status and Outlook (2012-2022)

2 GLOBAL OCULAR DRUG DELIVERY MARKET COMPETITION BY MANUFACTURERS

2.1 Global Ocular Drug Delivery Capacity, Production and Share by Manufacturers (2012-2017)
  2.1.1 Global Ocular Drug Delivery Capacity and Share by Manufacturers (2012-2017)
  2.1.2 Global Ocular Drug Delivery Production and Share by Manufacturers (2012-2017)
2.2 Global Ocular Drug Delivery Revenue and Share by Manufacturers (2012-2017)
2.3 Global Ocular Drug Delivery Average Price by Manufacturers (2012-2017)
2.4 Manufacturers Ocular Drug Delivery Manufacturing Base Distribution, Sales Area and Product Type
2.5 Ocular Drug Delivery Market Competitive Situation and Trends
  2.5.1 Ocular Drug Delivery Market Concentration Rate
  2.5.2 Ocular Drug Delivery Market Share of Top 3 and Top 5 Manufacturers
  2.5.3 Mergers & Acquisitions, Expansion

3 GLOBAL OCULAR DRUG DELIVERY CAPACITY, PRODUCTION, REVENUE (VALUE) BY REGION (2012-2017)

3.1 Global Ocular Drug Delivery Capacity and Market Share by Region (2012-2017)
3.2 Global Ocular Drug Delivery Production and Market Share by Region (2012-2017)
3.3 Global Ocular Drug Delivery Revenue (Value) and Market Share by Region (2012-2017)
3.4 Global Ocular Drug Delivery Capacity, Production, Revenue, Price and Gross Margin (2012-2017)
3.5 North America Ocular Drug Delivery Capacity, Production, Revenue, Price and Gross Margin (2012-2017)
3.6 Europe Ocular Drug Delivery Capacity, Production, Revenue, Price and Gross Margin (2012-2017)
3.7 China Ocular Drug Delivery Capacity, Production, Revenue, Price and Gross Margin (2012-2017)
3.8 Japan Ocular Drug Delivery Capacity, Production, Revenue, Price and Gross Margin (2012-2017)
3.9 Southeast Asia Ocular Drug Delivery Capacity, Production, Revenue, Price and Gross Margin (2012-2017)
3.10 India Ocular Drug Delivery Capacity, Production, Revenue, Price and Gross Margin (2012-2017)

4 GLOBAL OCULAR DRUG DELIVERY SUPPLY (PRODUCTION), CONSUMPTION, EXPORT, IMPORT BY REGION (2012-2017)

4.1 Global Ocular Drug Delivery Consumption by Region (2012-2017)
4.2 North America Ocular Drug Delivery Production, Consumption, Export, Import (2012-2017)
4.3 Europe Ocular Drug Delivery Production, Consumption, Export, Import (2012-2017)
4.4 China Ocular Drug Delivery Production, Consumption, Export, Import (2012-2017)
4.5 Japan Ocular Drug Delivery Production, Consumption, Export, Import (2012-2017)
4.6 Southeast Asia Ocular Drug Delivery Production, Consumption, Export, Import (2012-2017)
4.7 India Ocular Drug Delivery Production, Consumption, Export, Import (2012-2017)

5 GLOBAL OCULAR DRUG DELIVERY PRODUCTION, REVENUE (VALUE), PRICE TREND BY TYPE

5.1 Global Ocular Drug Delivery Production and Market Share by Type (2012-2017)
5.2 Global Ocular Drug Delivery Revenue and Market Share by Type (2012-2017)
5.3 Global Ocular Drug Delivery Price by Type (2012-2017)
5.4 Global Ocular Drug Delivery Production Growth by Type (2012-2017)

6 GLOBAL OCULAR DRUG DELIVERY MARKET ANALYSIS BY APPLICATION

6.1 Global Ocular Drug Delivery Consumption and Market Share by Application (2012-2017)
6.2 Global Ocular Drug Delivery Consumption Growth Rate by Application (2012-2017)
6.3 Market Drivers and Opportunities
  6.3.1 Potential Applications
  6.3.2 Emerging Markets/Countries

7 GLOBAL OCULAR DRUG DELIVERY MANUFACTURERS PROFILES/ANALYSIS

7.1 OCULAR THERAPEUTIX, INC
  7.1.1 Company Basic Information, Manufacturing Base, Sales Area and Its Competitors
  7.1.2 Ocular Drug Delivery Product Category, Application and Specification
    7.1.2.1 Product A
    7.1.2.2 Product B
  7.1.3 OCULAR THERAPEUTIX, INC Ocular Drug Delivery Capacity, Production, Revenue, Price and Gross Margin (2012-2017)
  7.1.4 Main Business/Business Overview
7.2 Alimera Sciences
  7.2.1 Company Basic Information, Manufacturing Base, Sales Area and Its Competitors
  7.2.2 Ocular Drug Delivery Product Category, Application and Specification
    7.2.2.1 Product A
    7.2.2.2 Product B
  7.2.3 Alimera Sciences Ocular Drug Delivery Capacity, Production, Revenue, Price and Gross Margin (2012-2017)
  7.2.4 Main Business/Business Overview
7.3 Allergan, Plc
  7.3.1 Company Basic Information, Manufacturing Base, Sales Area and Its Competitors
  7.3.2 Ocular Drug Delivery Product Category, Application and Specification
    7.3.2.1 Product A
    7.3.2.2 Product B
  7.3.3 Allergan, Plc Ocular Drug Delivery Capacity, Production, Revenue, Price and Gross Margin (2012-2017)
  7.3.4 Main Business/Business Overview
7.4 EyeGate Pharma
  7.4.1 Company Basic Information, Manufacturing Base, Sales Area and Its Competitors
  7.4.2 Ocular Drug Delivery Product Category, Application and Specification
    7.4.2.1 Product A
    7.4.2.2 Product B
  7.4.3 EyeGate Pharma Ocular Drug Delivery Capacity, Production, Revenue, Price and Gross Margin (2012-2017)
  7.4.4 Main Business/Business Overview
7.5 Valeant Pharmaceuticals International, Inc
  7.5.1 Company Basic Information, Manufacturing Base, Sales Area and Its Competitors
  7.5.2 Ocular Drug Delivery Product Category, Application and Specification
    7.5.2.1 Product A
    7.5.2.2 Product B
  7.5.3 Valeant Pharmaceuticals International, Inc Ocular Drug Delivery Capacity, Production, Revenue, Price and Gross Margin (2012-2017)
  7.5.4 Main Business/Business Overview
7.6 Envisia Therapeutics
  7.6.1 Company Basic Information, Manufacturing Base, Sales Area and Its Competitors
  7.6.2 Ocular Drug Delivery Product Category, Application and Specification
    7.6.2.1 Product A
    7.6.2.2 Product B
  7.6.3 Envisia Therapeutics Ocular Drug Delivery Capacity, Production, Revenue, Price and Gross Margin (2012-2017)
  7.6.4 Main Business/Business Overview
7.7 Clearside Biomedical
  7.7.1 Company Basic Information, Manufacturing Base, Sales Area and Its Competitors
  7.7.2 Ocular Drug Delivery Product Category, Application and Specification
    7.7.2.1 Product A
    7.7.2.2 Product B
  7.7.3 Clearside Biomedical Ocular Drug Delivery Capacity, Production, Revenue, Price and Gross Margin (2012-2017)
  7.7.4 Main Business/Business Overview
7.8 Graybug Vision Inc
  7.8.1 Company Basic Information, Manufacturing Base, Sales Area and Its Competitors
  7.8.2 Ocular Drug Delivery Product Category, Application and Specification
    7.8.2.1 Product A
    7.8.2.2 Product B
  7.8.3 Graybug Vision Inc Ocular Drug Delivery Capacity, Production, Revenue, Price and Gross Margin (2012-2017)
  7.8.4 Main Business/Business Overview
7.9 Taiwan Liposome Company
  7.9.1 Company Basic Information, Manufacturing Base, Sales Area and Its Competitors
  7.9.2 Ocular Drug Delivery Product Category, Application and Specification
    7.9.2.1 Product A
    7.9.2.2 Product B
  7.9.3 Taiwan Liposome Company Ocular Drug Delivery Capacity, Production, Revenue, Price and Gross Margin (2012-2017)
  7.9.4 Main Business/Business Overview
7.10 Santen Pharmaceutical Co., Ltd
  7.10.1 Company Basic Information, Manufacturing Base, Sales Area and Its Competitors
  7.10.2 Ocular Drug Delivery Product Category, Application and Specification
    7.10.2.1 Product A
    7.10.2.2 Product B
  7.10.3 Santen Pharmaceutical Co., Ltd Ocular Drug Delivery Capacity, Production, Revenue, Price and Gross Margin (2012-2017)
  7.10.4 Main Business/Business Overview

8 OCULAR DRUG DELIVERY MANUFACTURING COST ANALYSIS

8.1 Ocular Drug Delivery Key Raw Materials Analysis
  8.1.1 Key Raw Materials
  8.1.2 Price Trend of Key Raw Materials
  8.1.3 Key Suppliers of Raw Materials
  8.1.4 Market Concentration Rate of Raw Materials
8.2 Proportion of Manufacturing Cost Structure
  8.2.1 Raw Materials
  8.2.2 Labor Cost
  8.2.3 Manufacturing Expenses
8.3 Manufacturing Process Analysis of Ocular Drug Delivery

9 INDUSTRIAL CHAIN, SOURCING STRATEGY AND DOWNSTREAM BUYERS

9.1 Ocular Drug Delivery Industrial Chain Analysis
9.2 Upstream Raw Materials Sourcing
9.3 Raw Materials Sources of Ocular Drug Delivery Major Manufacturers in 2015
9.4 Downstream Buyers

10 MARKETING STRATEGY ANALYSIS, DISTRIBUTORS/TRADERS

10.1 Marketing Channel
  10.1.1 Direct Marketing
  10.1.2 Indirect Marketing
  10.1.3 Marketing Channel Development Trend
10.2 Market Positioning
  10.2.1 Pricing Strategy
  10.2.2 Brand Strategy
  10.2.3 Target Client
10.3 Distributors/Traders List

11 MARKET EFFECT FACTORS ANALYSIS

11.1 Technology Progress/Risk
  11.1.1 Substitutes Threat
  11.1.2 Technology Progress in Related Industry
11.2 Consumer Needs/Customer Preference Change
11.3 Economic/Political Environmental Change

12 GLOBAL OCULAR DRUG DELIVERY MARKET FORECAST (2017-2022)

12.1 Global Ocular Drug Delivery Capacity, Production, Revenue Forecast (2017-2022)
  12.1.1 Global Ocular Drug Delivery Capacity, Production and Growth Rate Forecast (2017-2022)
  12.1.2 Global Ocular Drug Delivery Revenue and Growth Rate Forecast (2017-2022)
  12.1.3 Global Ocular Drug Delivery Price and Trend Forecast (2017-2022)
12.2 Global Ocular Drug Delivery Production, Consumption, Import and Export Forecast by Region (2017-2022)
  12.2.1 North America Ocular Drug Delivery Production, Revenue, Consumption, Export and Import Forecast (2017-2022)
  12.2.2 Europe Ocular Drug Delivery Production, Revenue, Consumption, Export and Import Forecast (2017-2022)
  12.2.3 China Ocular Drug Delivery Production, Revenue, Consumption, Export and Import Forecast (2017-2022)
  12.2.4 Japan Ocular Drug Delivery Production, Revenue, Consumption, Export and Import Forecast (2017-2022)
  12.2.5 Southeast Asia Ocular Drug Delivery Production, Revenue, Consumption, Export and Import Forecast (2017-2022)
  12.2.6 India Ocular Drug Delivery Production, Revenue, Consumption, Export and Import Forecast (2017-2022)
12.3 Global Ocular Drug Delivery Production, Revenue and Price Forecast by Type (2017-2022)
12.4 Global Ocular Drug Delivery Consumption Forecast by Application (2017-2022)

13 RESEARCH FINDINGS AND CONCLUSION

14 APPENDIX

14.1 Methodology/Research Approach
  14.1.1 Research Programs/Design
  14.1.2 Market Size Estimation
  14.1.3 Market Breakdown and Data Triangulation
14.2 Data Source
  14.2.1 Secondary Sources
  14.2.2 Primary Sources
14.3 Disclaimer


The report requires updating with new data and is sent in 2-3 business days after order is placed.

List Of Tables

LIST OF TABLES AND FIGURES

Figure Picture of Ocular Drug Delivery
Figure Global Ocular Drug Delivery Production (K Doses) and CAGR (%) Comparison by Types (Product Category) (2012-2022)
Figure Global Ocular Drug Delivery Production Market Share by Types (Product Category) in 2016
Figure Product Picture of Ocular Insert
Table Major Manufacturers of Ocular Insert
Figure Product Picture of Iontophoresis
Table Major Manufacturers of Iontophoresis
Figure Product Picture of Intraocular Implants
Table Major Manufacturers of Intraocular Implants
Figure Product Picture of In Situ Gel & Punctal Plugs
Table Major Manufacturers of In Situ Gel & Punctal Plugs
Figure Product Picture of Others
Table Major Manufacturers of Others
Figure Global Ocular Drug Delivery Consumption (K Doses) by Applications (2012-2022)
Figure Global Ocular Drug Delivery Consumption Market Share by Applications in 2016
Figure Hospitals Examples
Table Key Downstream Customer in Hospitals
Figure Ambulatory Surgical Centers Examples
Table Key Downstream Customer in Ambulatory Surgical Centers
Figure Ophthalmic Clinics Examples
Table Key Downstream Customer in Ophthalmic Clinics
Figure Homecare Settings Examples
Table Key Downstream Customer in Homecare Settings
Figure Global Ocular Drug Delivery Market Size (Million USD), Comparison (K Doses) and CAGR (%) by Regions (2012-2022)
Figure North America Ocular Drug Delivery Revenue (Million USD) and Growth Rate (2012-2022)
Figure Europe Ocular Drug Delivery Revenue (Million USD) and Growth Rate (2012-2022)
Figure China Ocular Drug Delivery Revenue (Million USD) and Growth Rate (2012-2022)
Figure Japan Ocular Drug Delivery Revenue (Million USD) and Growth Rate (2012-2022)
Figure Southeast Asia Ocular Drug Delivery Revenue (Million USD) and Growth Rate (2012-2022)
Figure India Ocular Drug Delivery Revenue (Million USD) and Growth Rate (2012-2022)
Figure Global Ocular Drug Delivery Revenue (Million USD) Status and Outlook (2012-2022)
Figure Global Ocular Drug Delivery Capacity, Production (K Doses) Status and Outlook (2012-2022)
Figure Global Ocular Drug Delivery Major Players Product Capacity (K Doses) (2012-2017)
Table Global Ocular Drug Delivery Capacity (K Doses) of Key Manufacturers (2012-2017)
Table Global Ocular Drug Delivery Capacity Market Share of Key Manufacturers (2012-2017)
Figure Global Ocular Drug Delivery Capacity (K Doses) of Key Manufacturers in 2016
Figure Global Ocular Drug Delivery Capacity (K Doses) of Key Manufacturers in 2017
Figure Global Ocular Drug Delivery Major Players Product Production (K Doses) (2012-2017)
Table Global Ocular Drug Delivery Production (K Doses) of Key Manufacturers (2012-2017)
Table Global Ocular Drug Delivery Production Share by Manufacturers (2012-2017)
Figure 2016 Ocular Drug Delivery Production Share by Manufacturers
Figure 2017 Ocular Drug Delivery Production Share by Manufacturers
Figure Global Ocular Drug Delivery Major Players Product Revenue (Million USD) (2012-2017)
Table Global Ocular Drug Delivery Revenue (Million USD) by Manufacturers (2012-2017)
Table Global Ocular Drug Delivery Revenue Share by Manufacturers (2012-2017)
Table 2016 Global Ocular Drug Delivery Revenue Share by Manufacturers
Table 2017 Global Ocular Drug Delivery Revenue Share by Manufacturers
Table Global Market Ocular Drug Delivery Average Price (USD/Dose) of Key Manufacturers (2012-2017)
Figure Global Market Ocular Drug Delivery Average Price (USD/Dose) of Key Manufacturers in 2016
Table Manufacturers Ocular Drug Delivery Manufacturing Base Distribution and Sales Area
Table Manufacturers Ocular Drug Delivery Product Category
Figure Ocular Drug Delivery Market Share of Top 3 Manufacturers
Figure Ocular Drug Delivery Market Share of Top 5 Manufacturers
Table Global Ocular Drug Delivery Capacity (K Doses) by Region (2012-2017)
Figure Global Ocular Drug Delivery Capacity Market Share by Region (2012-2017)
Figure Global Ocular Drug Delivery Capacity Market Share by Region (2012-2017)
Figure 2016 Global Ocular Drug Delivery Capacity Market Share by Region
Table Global Ocular Drug Delivery Production by Region (2012-2017)
Figure Global Ocular Drug Delivery Production (K Doses) by Region (2012-2017)
Figure Global Ocular Drug Delivery Production Market Share by Region (2012-2017)
Figure 2016 Global Ocular Drug Delivery Production Market Share by Region
Table Global Ocular Drug Delivery Revenue (Million USD) by Region (2012-2017)
Table Global Ocular Drug Delivery Revenue Market Share by Region (2012-2017)
Figure Global Ocular Drug Delivery Revenue Market Share by Region (2012-2017)
Table 2016 Global Ocular Drug Delivery Revenue Market Share by Region
Figure Global Ocular Drug Delivery Capacity, Production (K Doses) and Growth Rate (2012-2017)
Table Global Ocular Drug Delivery Capacity, Production (K Doses), Revenue (Million USD), Price (USD/Dose) and Gross Margin (2012-2017)
Table North America Ocular Drug Delivery Capacity, Production (K Doses), Revenue (Million USD), Price (USD/Dose) and Gross Margin (2012-2017)
Table Europe Ocular Drug Delivery Capacity, Production (K Doses), Revenue (Million USD), Price (USD/Dose) and Gross Margin (2012-2017)
Table China Ocular Drug Delivery Capacity, Production (K Doses), Revenue (Million USD), Price (USD/Dose) and Gross Margin (2012-2017)
Table Japan Ocular Drug Delivery Capacity, Production (K Doses), Revenue (Million USD), Price (USD/Dose) and Gross Margin (2012-2017)
Table Southeast Asia Ocular Drug Delivery Capacity, Production (K Doses), Revenue (Million USD), Price (USD/Dose) and Gross Margin (2012-2017)
Table India Ocular Drug Delivery Capacity, Production (K Doses), Revenue (Million USD), Price (USD/Dose) and Gross Margin (2012-2017)
Table Global Ocular Drug Delivery Consumption (K Doses) Market by Region (2012-2017)
Table Global Ocular Drug Delivery Consumption Market Share by Region (2012-2017)
Figure Global Ocular Drug Delivery Consumption Market Share by Region (2012-2017)
Figure 2016 Global Ocular Drug Delivery Consumption (K Doses) Market Share by Region
Table North America Ocular Drug Delivery Production, Consumption, Import & Export (K Doses) (2012-2017)
Table Europe Ocular Drug Delivery Production, Consumption, Import & Export (K Doses) (2012-2017)
Table China Ocular Drug Delivery Production, Consumption, Import & Export (K Doses) (2012-2017)
Table Japan Ocular Drug Delivery Production, Consumption, Import & Export (K Doses) (2012-2017)
Table Southeast Asia Ocular Drug Delivery Production, Consumption, Import & Export (K Doses) (2012-2017)
Table India Ocular Drug Delivery Production, Consumption, Import & Export (K Doses) (2012-2017)
Table Global Ocular Drug Delivery Production (K Doses) by Type (2012-2017)
Table Global Ocular Drug Delivery Production Share by Type (2012-2017)
Figure Production Market Share of Ocular Drug Delivery by Type (2012-2017)
Figure 2016 Production Market Share of Ocular Drug Delivery by Type
Table Global Ocular Drug Delivery Revenue (Million USD) by Type (2012-2017)
Table Global Ocular Drug Delivery Revenue Share by Type (2012-2017)
Figure Production Revenue Share of Ocular Drug Delivery by Type (2012-2017)
Figure 2016 Revenue Market Share of Ocular Drug Delivery by Type
Table Global Ocular Drug Delivery Price (USD/Dose) by Type (2012-2017)
Figure Global Ocular Drug Delivery Production Growth by Type (2012-2017)
Table Global Ocular Drug Delivery Consumption (K Doses) by Application (2012-2017)
Table Global Ocular Drug Delivery Consumption Market Share by Application (2012-2017)
Figure Global Ocular Drug Delivery Consumption Market Share by Applications (2012-2017)
Figure Global Ocular Drug Delivery Consumption Market Share by Application in 2016
Table Global Ocular Drug Delivery Consumption Growth Rate by Application (2012-2017)
Figure Global Ocular Drug Delivery Consumption Growth Rate by Application (2012-2017)
Table OCULAR THERAPEUTIX, INC Basic Information, Manufacturing Base, Sales Area and Its Competitors
Table OCULAR THERAPEUTIX, INC Ocular Drug Delivery Capacity, Production (K Doses), Revenue (Million USD), Price (USD/Dose) and Gross Margin (2012-2017)
Figure OCULAR THERAPEUTIX, INC Ocular Drug Delivery Production Growth Rate (2012-2017)
Figure OCULAR THERAPEUTIX, INC Ocular Drug Delivery Production Market Share (2012-2017)
Figure OCULAR THERAPEUTIX, INC Ocular Drug Delivery Revenue Market Share (2012-2017)
Table Alimera Sciences Basic Information, Manufacturing Base, Sales Area and Its Competitors
Table Alimera Sciences Ocular Drug Delivery Capacity, Production (K Doses), Revenue (Million USD), Price (USD/Dose) and Gross Margin (2012-2017)
Figure Alimera Sciences Ocular Drug Delivery Production Growth Rate (2012-2017)
Figure Alimera Sciences Ocular Drug Delivery Production Market Share (2012-2017)
Figure Alimera Sciences Ocular Drug Delivery Revenue Market Share (2012-2017)
Table Allergan, Plc Basic Information, Manufacturing Base, Sales Area and Its Competitors
Table Allergan, Plc Ocular Drug Delivery Capacity, Production (K Doses), Revenue (Million USD), Price (USD/Dose) and Gross Margin (2012-2017)
Figure Allergan, Plc Ocular Drug Delivery Production Growth Rate (2012-2017)
Figure Allergan, Plc Ocular Drug Delivery Production Market Share (2012-2017)
Figure Allergan, Plc Ocular Drug Delivery Revenue Market Share (2012-2017)
Table EyeGate Pharma Basic Information, Manufacturing Base, Sales Area and Its Competitors
Table EyeGate Pharma Ocular Drug Delivery Capacity, Production (K Doses), Revenue (Million USD), Price (USD/Dose) and Gross Margin (2012-2017)
Figure EyeGate Pharma Ocular Drug Delivery Production Growth Rate (2012-2017)
Figure EyeGate Pharma Ocular Drug Delivery Production Market Share (2012-2017)
Figure EyeGate Pharma Ocular Drug Delivery Revenue Market Share (2012-2017)
Table Valeant Pharmaceuticals International, Inc Basic Information, Manufacturing Base, Sales Area and Its Competitors
Table Valeant Pharmaceuticals International, Inc Ocular Drug Delivery Capacity, Production (K Doses), Revenue (Million USD), Price (USD/Dose) and Gross Margin (2012-2017)
Figure Valeant Pharmaceuticals International, Inc Ocular Drug Delivery Production Growth Rate (2012-2017)
Figure Valeant Pharmaceuticals International, Inc Ocular Drug Delivery Production Market Share (2012-2017)
Figure Valeant Pharmaceuticals International, Inc Ocular Drug Delivery Revenue Market Share (2012-2017)
Table Envisia Therapeutics Basic Information, Manufacturing Base, Sales Area and Its Competitors
Table Envisia Therapeutics Ocular Drug Delivery Capacity, Production (K Doses), Revenue (Million USD), Price (USD/Dose) and Gross Margin (2012-2017)
Figure Envisia Therapeutics Ocular Drug Delivery Production Growth Rate (2012-2017)
Figure Envisia Therapeutics Ocular Drug Delivery Production Market Share (2012-2017)
Figure Envisia Therapeutics Ocular Drug Delivery Revenue Market Share (2012-2017)
Table Clearside Biomedical Basic Information, Manufacturing Base, Sales Area and Its Competitors
Table Clearside Biomedical Ocular Drug Delivery Capacity, Production (K Doses), Revenue (Million USD), Price (USD/Dose) and Gross Margin (2012-2017)
Figure Clearside Biomedical Ocular Drug Delivery Production Growth Rate (2012-2017)
Figure Clearside Biomedical Ocular Drug Delivery Production Market Share (2012-2017)
Figure Clearside Biomedical Ocular Drug Delivery Revenue Market Share (2012-2017)
Table Graybug Vision Inc Basic Information, Manufacturing Base, Sales Area and Its Competitors
Table Graybug Vision Inc Ocular Drug Delivery Capacity, Production (K Doses), Revenue (Million USD), Price (USD/Dose) and Gross Margin (2012-2017)
Figure Graybug Vision Inc Ocular Drug Delivery Production Growth Rate (2012-2017)
Figure Graybug Vision Inc Ocular Drug Delivery Production Market Share (2012-2017)
Figure Graybug Vision Inc Ocular Drug Delivery Revenue Market Share (2012-2017)
Table Taiwan Liposome Company Basic Information, Manufacturing Base, Sales Area and Its Competitors
Table Taiwan Liposome Company Ocular Drug Delivery Capacity, Production (K Doses), Revenue (Million USD), Price (USD/Dose) and Gross Margin (2012-2017)
Figure Taiwan Liposome Company Ocular Drug Delivery Production Growth Rate (2012-2017)
Figure Taiwan Liposome Company Ocular Drug Delivery Production Market Share (2012-2017)
Figure Taiwan Liposome Company Ocular Drug Delivery Revenue Market Share (2012-2017)
Table Santen Pharmaceutical Co., Ltd Basic Information, Manufacturing Base, Sales Area and Its Competitors
Table Santen Pharmaceutical Co., Ltd Ocular Drug Delivery Capacity, Production (K Doses), Revenue (Million USD), Price (USD/Dose) and Gross Margin (2012-2017)
Figure Santen Pharmaceutical Co., Ltd Ocular Drug Delivery Production Growth Rate (2012-2017)
Figure Santen Pharmaceutical Co., Ltd Ocular Drug Delivery Production Market Share (2012-2017)
Figure Santen Pharmaceutical Co., Ltd Ocular Drug Delivery Revenue Market Share (2012-2017)
Table Production Base and Market Concentration Rate of Raw Material
Figure Price Trend of Key Raw Materials
Table Key Suppliers of Raw Materials
Figure Manufacturing Cost Structure of Ocular Drug Delivery
Figure Manufacturing Process Analysis of Ocular Drug Delivery
Figure Ocular Drug Delivery Industrial Chain Analysis
Table Raw Materials Sources of Ocular Drug Delivery Major Manufacturers in 2016
Table Major Buyers of Ocular Drug Delivery
Table Distributors/Traders List
Figure Global Ocular Drug Delivery Capacity, Production (K Doses) and Growth Rate Forecast (2017-2022)
Figure Global Ocular Drug Delivery Revenue (Million USD) and Growth Rate Forecast (2017-2022)
Figure Global Ocular Drug Delivery Price (Million USD) and Trend Forecast (2017-2022)
Table Global Ocular Drug Delivery Production (K Doses) Forecast by Region (2017-2022)
Figure Global Ocular Drug Delivery Production Market Share Forecast by Region (2017-2022)
Table Global Ocular Drug Delivery Consumption (K Doses) Forecast by Region (2017-2022)
Figure Global Ocular Drug Delivery Consumption Market Share Forecast by Region (2017-2022)
Figure North America Ocular Drug Delivery Production (K Doses) and Growth Rate Forecast (2017-2022)
Figure North America Ocular Drug Delivery Revenue (Million USD) and Growth Rate Forecast (2017-2022)
Table North America Ocular Drug Delivery Production, Consumption, Export and Import (K Doses) Forecast (2017-2022)
Figure Europe Ocular Drug Delivery Production (K Doses) and Growth Rate Forecast (2017-2022)
Figure Europe Ocular Drug Delivery Revenue (Million USD) and Growth Rate Forecast (2017-2022)
Table Europe Ocular Drug Delivery Production, Consumption, Export and Import (K Doses) Forecast (2017-2022)
Figure China Ocular Drug Delivery Production (K Doses) and Growth Rate Forecast (2017-2022)
Figure China Ocular Drug Delivery Revenue (Million USD) and Growth Rate Forecast (2017-2022)
Table China Ocular Drug Delivery Production, Consumption, Export and Import (K Doses) Forecast (2017-2022)
Figure Japan Ocular Drug Delivery Production (K Doses) and Growth Rate Forecast (2017-2022)
Figure Japan Ocular Drug Delivery Revenue (Million USD) and Growth Rate Forecast (2017-2022)
Table Japan Ocular Drug Delivery Production, Consumption, Export and Import (K Doses) Forecast (2017-2022)
Figure Southeast Asia Ocular Drug Delivery Production (K Doses) and Growth Rate Forecast (2017-2022)
Figure Southeast Asia Ocular Drug Delivery Revenue (Million USD) and Growth Rate Forecast (2017-2022)
Table Southeast Asia Ocular Drug Delivery Production, Consumption, Export and Import (K Doses) Forecast (2017-2022)
Figure India Ocular Drug Delivery Production (K Doses) and Growth Rate Forecast (2017-2022)
Figure India Ocular Drug Delivery Revenue (Million USD) and Growth Rate Forecast (2017-2022)
Table India Ocular Drug Delivery Production, Consumption, Export and Import (K Doses) Forecast (2017-2022)
Table Global Ocular Drug Delivery Production (K Doses) Forecast by Type (2017-2022)
Figure Global Ocular Drug Delivery Production (K Doses) Forecast by Type (2017-2022)
Table Global Ocular Drug Delivery Revenue (Million USD) Forecast by Type (2017-2022)
Figure Global Ocular Drug Delivery Revenue Market Share Forecast by Type (2017-2022)
Table Global Ocular Drug Delivery Price Forecast by Type (2017-2022)
Table Global Ocular Drug Delivery Consumption (K Doses) Forecast by Application (2017-2022)
Figure Global Ocular Drug Delivery Consumption (K Doses) Forecast by Application (2017-2022)
Table Research Programs/Design for This Report
Figure Bottom-up and Top-down Approaches for This Report
Figure Data Triangulation
Table Key Data Information from Secondary Sources
Table Key Data Information from Primary Source